Skye Bioscience, Inc. (SKYE) › Net IncomeSkye Bioscience, Inc. (SKYE) — Net IncomeAnnual figures by fiscal year, from SEC filings.2012: $4.5K2013: -$120.4K2014: -$2.73M2015: -$4.84M2016: -$3.18M2017: -$3.09M2018: -$19.19M2019: $1.05M2020: -$6.56M2021: -$8.52M2022: -$19.48M2023: -$37.64M2024: -$26.57M2025: -$55.92M-$55.92M2012Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$55.92M-110.5%2024-$26.57M+29.4%2023-$37.64M-93.2%2022-$19.48M-128.6%2021-$8.52M-29.9%2020-$6.56M-723.7%2019$1.05M+105.5%2018-$19.19M-520.3%2017-$3.09M+2.6%2016-$3.18M+34.4%2015-$4.84M-77.1%2014-$2.73M-2170.8%2013-$120.4K-2770.3%2012$4.5K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share